Tag: Mayo Clinic
Phenomix Sciences Announces First Obesity Biobank Registry to Study Underlying Phenotypes
On a mission to conquer obesity, Phenomix Sciences has launched its first obesity biobanking registry and outcomes study. The registry will study variability in obesity by looking at genetic and environmental factors in patients, and analyze interventions that will...
Cytox To Make Use Of Mayo Clinic’s Alzheimer’s Biobank
Cytox is a precision medicine company with a focus on neurodegenerative disorders such as Alzheimer’s disease. The Cytox scientific and proprietary technology platform is being applied to the prediction of cognitive decline and neurodegenerative disorder risk. The Mayo Clinic is...
